{"id":"NCT02497469","sponsor":"Takeda","briefTitle":"An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis","officialTitle":"A Randomized, Double-Blind, Double-Dummy, Multicenter, Active-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab IV Compared to Adalimumab SC in Subjects With Ulcerative Colitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-29","primaryCompletion":"2018-09-26","completion":"2019-01-18","firstPosted":"2015-07-14","resultsPosted":"2019-10-10","lastUpdate":"2020-01-28"},"enrollment":771,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Colitis, Ulcerative"],"interventions":[{"type":"DRUG","name":"Vedolizumab","otherNames":[]},{"type":"DRUG","name":"Adalimumab placebo","otherNames":[]},{"type":"DRUG","name":"Adalimumab","otherNames":[]},{"type":"DRUG","name":"Vedolizumab placebo","otherNames":[]}],"arms":[{"label":"Vedolizumab IV 300 mg","type":"EXPERIMENTAL"},{"label":"Adalimumab SC 160/80/40 mg","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) treatment over a 52-week treatment period.","primaryOutcome":{"measure":"Percentage of Participants Who Achieved Clinical Remission","timeFrame":"Week 52","effectByArm":[{"arm":"Adalimumab SC, 160/80/40 mg","deltaMin":22.5,"sd":null},{"arm":"Vedolizumab IV 300 mg","deltaMin":31.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0061"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":330,"countries":["United States","Argentina","Australia","Belgium","Bosnia and Herzegovina","Bulgaria","Canada","Colombia","Croatia","Czechia","Denmark","Estonia","France","Germany","Hong Kong","Hungary","Israel","Italy","Latvia","Lithuania","Mexico","Netherlands","Poland","Portugal","Romania","Russia","Serbia","Slovakia","South Korea","Spain","Taiwan","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["35934286","34144047","31553834"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":53,"n":386},"commonTop":["Colitis ulcerative","Nasopharyngitis","Headache","Anaemia","Upper respiratory tract infection"]}}